IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q1 2025 Holdings

Filed 2025-05-07 | 27 holdings | $123.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals Inc(AVIR)COM04683R106$22.8M7,609,81218.4%
Aclaris Therapeutics Inc(ACRS)COM00461U105$21.8M14,250,00017.6%
Third Harmonic BIO Inc(THRD)COM88427A107$13.3M3,824,41710.7%
Adverum Biotechnologies Inc(AVU0)COM NEW00773U207$12.0M2,742,3179.7%
An2 Therapeutics Inc(ANTX)COM037326105$7.8M5,749,4326.3%
Instil BIO Inc(TIL)COM NEW45783C200$7.2M416,7205.9%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$6.7M4,221,5465.4%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$6.5M3,020,7485.2%
Ikena Oncology IncCOM45175G108$4.7M3,710,8033.8%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$4.1M3,747,6123.3%
Whitehawk Therapeutics Inc(WHWK)COM00032Q104$3.4M1,890,2452.7%
Lava Therapeutics NVSHSN51517105$2.5M1,960,6102.0%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$2.0M408,1381.6%
Elevation Oncology IncCOM28623U101$1.5M5,890,9341.2%
Astrotech Corp(ASTC)COM046484309$1.4M220,4101.2%
Connect Biopharma Hldgs LTDADS207523101$1.2M2,093,2320.9%
Sage Therapeutics Inc(SG7)COM78667J108$1.1M135,0950.9%
Athira Pharma IncCOM04746L104$911.9K3,200,6670.7%
Milestone Pharmaceuticals in(MIST)COM59935V107$909.0K1,136,0910.7%
Lisata Therapeutics Inc(LSTA)COM128058302$509.6K216,8530.4%
Turnstone Biologics CorpCOM90042W100$452.4K1,103,3860.4%
Vistagen Therapeutics Inc(VTGN)COM92840H400$375.0K150,0000.3%
Alumis Inc(ALMS)COM022307102$304.7K49,6270.2%
Nextcure IncCOM65343E108$131.4K273,5360.1%
Verrica Pharmaceuticals IncCOM92511W108$77.2K174,6510.1%
Hillevax IncCOM43157M102$30.1K20,7600.0%
Achilles Therapeutics PLC(698)SPONSORED ADS00449L102$03,804,9210.0%